v3.25.2
BACKGROUND AND ORGANIZATION (Details Narrative)
Aug. 30, 2022
₨ / shares
shares
Jun. 30, 2025
$ / shares
shares
Dec. 31, 2024
$ / shares
shares
Oct. 25, 2024
Mar. 17, 2022
$ / shares
shares
Sep. 21, 2018
$ / shares
shares
Oct. 05, 2017
$ / shares
shares
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock authorized shares   400,000,000 400,000,000        
Common stock par value | $ / shares   $ 0.001 $ 0.001        
Common stock, shares authorized   50,000,000 50,000,000        
Preferred stock, par value | $ / shares   $ 0.001 $ 0.001        
Common stock shares issued   88,992,243 86,782,908        
Common stock shares outstanding   88,992,243 86,782,908        
Pharmalectin India Pv tLtd [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock authorized shares 50,000            
Common stock par value | ₨ / shares ₨ 10            
Common stock shares outstanding 41,020            
Outstanding shares round off 41,000       50,000    
Outstanding shares percentage 99.95%            
Pharmalectin (BVI), Inc. [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock authorized shares         50,000    
Common stock par value | $ / shares         $ 1.00    
NDPD Pharma Inc [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock authorized shares             95,000,000
Common stock par value | $ / shares             $ 0.0001
Common stock, shares authorized             5,000,000
Preferred stock, par value | $ / shares             $ 0.0001
Common stock shares issued   15,000,000          
Common stock shares outstanding   15,000,000          
Percentage acquired       100.00%      
Parent Company [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock authorized shares           400,000,000 95,000,000
Common stock par value | $ / shares           $ 0.001 $ 0.0001
Common stock, shares authorized           50,000,000 5,000,000
Preferred stock, par value | $ / shares           $ 0.001 $ 0.0001
Pharmalectin, Inc. [Member]              
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]              
Common stock authorized shares             95,000,000
Common stock par value | $ / shares             $ 0.0001
Common stock, shares authorized             5,000,000
Preferred stock, par value | $ / shares             $ 0.0001
Common stock shares issued   15,000,000          
Common stock shares outstanding   15,000,000